CCS is actively monitoring and responding to the recommendations of the Public Health Agency of Canada regarding coronavirus disease (COVID-19).
Treatments for stage 4S neuroblastoma
There is no standard treatment for stage 4S neuroblastoma, and many children may not need to have any treatment. If your child doesn’t have any symptoms or unfavourable prognostic factors, they may just need watchful waiting, or observation. Children with symptoms or unfavourable prognostic factors may be treated with chemotherapy. Surgery may not be necessary for stage 4S neuroblastoma other than a biopsy of the primary site or a site where the disease has spread.
Watchful waiting may be the only treatment needed for children with stage 4S neuroblastoma who don’t have any symptoms. Often these tumours will disappear on their own or will turn into a non-cancerous ganglioneuroma. If symptoms develop, doctors may offer chemotherapy or other treatments available in a clinical trial.
Chemotherapy is sometimes used to treat stage 4S neuroblastoma if children have symptoms or unfavourable prognostic factors.
Chemotherapy drugs that may be used include:
- etoposide (Vepesid, VP-16)
- cyclophosphamide (Cytoxan, Procytox)
- carboplatin (Paraplatin, Paraplatin AQ)
- doxorubicin (Adriamycin)
- vincristine (Oncovin)
Many children with stage 4S neuroblastoma are treated in a clinical trial. Clinical trials look at new and better ways to prevent, find and treat cancer. Find out more about clinical trials.
Making progress in the cancer fight
The 5-year cancer survival rate has increased from 25% in the 1940s to 60% today.